According to FutureWise analysis the market for Combo IVD in 2023 is US$ 582.7 million, and is expected to reach US$ around 912 billion by 2031 at a CAGR of 6.20%.
Combo in vitro diagnostics (IVDs) refers to medical tools that measure and analyze biological samples in a controlled environment. These tests are valuable for detecting and monitoring a wide range of medical conditions, including infectious diseases and autoimmune disorders. They are also sometimes used to track changes in medication treatments. The increasing number of people affected by infectious and chronic diseases is driving growth in the in vitro diagnostics industry. Modern workplaces are seeing a concerning rise in long-term health issues, including diabetes, cancer, heart disease, and tuberculosis. Additionally, there have been significant increases in cases of infectious diseases, respiratory illnesses, and gastrointestinal problems.
The rising prevalence of various disorders is expected to increase the demand for diagnostic equipment, thereby driving the in vitro diagnostic (IVD) market. Improved healthcare infrastructure, a higher incidence of chronic health conditions, unmet healthcare needs, and the growing demand for advanced in vitro diagnostic testing are anticipated to contribute to significant growth in untapped emerging markets. Additionally, innovations in in vitro diagnostics are propelling the market forward.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Combo IVD Market trends that shall affect the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Combo-IVD-Market/15634
Combo IVD Market Segmentation:
By Test Type
- SARS-CoV-2 Flu A/B Combo Test
- COVID-19, Influenza A/B, RSV Combo test
- COVID-19 IgM/IgG Combo Test
- HIV-1/2 Ag/Ab Combo Test
- HIV/Syphilis Ab Combo Test
- HIV, HBsAg, HCV & Syphilis Combo
- hCG Combo Test
- Thrombophilia Detection Combo Test
- Other Test Types
By Testing
- Rapid testing
- Point of care testing
By End-User
- Diagnostics centres
- Hospitals
- Homecare setting
- Other End-Users
By Channel
- Over-the-Counter
- Laboratory based
By Sample Type
- Orals and Nasal Swabs
- Human Serum
- Whole Blood
- Other Sample Types
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Combo IVD Market:
- DRG International Inc.
- Becton, Dickinson and Company
- DiaCarta Inc
- Abbott
- bioMérieux SA4
- Bio-Rad Laboratories
- Alpha IVD Srl
- BioGX BV
- Thermo Fisher Scientific Inc.
- Megna Health Inc
- CTK Biotech, Inc.
- Biopanda Reagents Ltd
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=15634&license=single
**Objectives of this Study: **
- To provide a comprehensive analysis of the Combo IVD Market By Test Type, By Testing, By End-User, By Channel, By Sample Type, and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com